🇺🇸 FDA
Patent

US 12018052

Methods of detection and removal of rhabdoviruses from cell lines

granted A61KA61K2039/5258A61K39/205

Quick answer

US patent 12018052 (Methods of detection and removal of rhabdoviruses from cell lines) held by Takeda Vaccines, Inc. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/5258, A61K39/205